Journals / Kulak Burun Boğaz Uygulamaları / 2018 / Cilt: 6 - Sayı: 1

Approach to the patient with sialorrhea and treatment management

Siyaloreli hastaya yaklaşım ve tedavi yönetimi

Pages
39–47
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Parotid ductus ligation, submandibular ductus rerouting, and excision of sublingual glands are the most effective and minimally invasive methods.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Drooling of saliva or sialorrhea is a clinical expression of a dysfunction in the coordination of the oral phase of swallowing mechanism.
📊
Key Findings & Data:Physical and psychosocial complications of sialorrhea can cause significant negative effects on physical health and quality of life.
💡
Conclusion & Impact:Parotid ductus ligation, submandibular ductus rerouting, and excision of sublingual glands are the most effective and minimally invasive methods.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Drooling of saliva or sialorrhea is a clinical expression of a dysfunction in the coordination of the oral phase of swallowing mechanism. It is caused by an inability to swallow saliva frequently, rather than by an excessive production of saliva in neurologically impaired patients. Physical and psychosocial complications of sialorrhea can cause significant negative effects on physical health and quality of life. Current treatment options of sialorrhea are oral motor therapy, behavioral therapies, orthodontic therapy, medical treatments such as anticholinergics, radiotherapy, injection of botulinum toxin, and surgical treatments. Status of the quality of patient’s life determines necessity of treatment. Treatments are administered gradually from minimally invasive to most invasive. Treatment of sialorrhea is best implemented by team work. Surgical treatments are ductus rerouting that diverts salivary flow or ductus ligation, submandibular and/or sublingual gland excision, and tympanic neurectomy with or without chorda tympani section, which decrease salivary secretion. Parotid ductus ligation, submandibular ductus rerouting, and excision of sublingual glands are the most effective and minimally invasive methods.

Özet

Tükürük artışı veya siyalore, yutma mekanizmasının oralfazının koordinasyonunda bir fonksiyon bozukluğunun klinikifadesidir. Nörolojik bozukluğu olan hastalarda siyaloreye aşırıtükürük üretiminden çok tükürüğün sıklıkla yutulamamasıneden olur. Siyalorenin fiziksel ve psikososyal komplikasyonlarıfiziksel sağlık ve yaşam kalitesi üzerinde belirgin olumsuzetkilere neden olabilir. Siyalorenin güncel tedavi seçeneklerioral motor terapi, davranış terapileri, ortodontik terapi;antikolinerjikler, radyoterapi, botulinum toksin enjeksiyonugibi tıbbi tedaviler ve cerrahi tedavilerdir. Hastanın yaşamkalitesinin durumu tedavi gerekliliğini belirler. Tedaviler, enaz invazivden en invazive doğru basamaklı uygulanır. Siyaloretedavisi takım çalışması ile en iyi şekilde gerçekleştirilir.Cerrahi tedaviler; tükürük akışını yönlendiren duktusunyönünün değiştirilmesi veya tükürük salgılanmasını azaltanduktus ligasyonu, submandibüler veya sublingual bez eksizyonuve korda timpani kesili veya kesisiz timpanik nörektomidir.Parotis duktus ligasyonu, submandibüler duktusun yönünündeğiştirilmesi ve sublingual bezlerin eksizyonu en etkili ve enaz invaziv yöntemlerdir.

🔖

Cite This Article

ÖZTURAN, O., ÇALIM, Ö. F. (2018). Approach to the patient with sialorrhea and treatment management. Kulak Burun Boğaz Uygulamaları, Cilt: 6 - Sayı: 1, 39–47. https://ajindex.com/articles/343544

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Stuchell RN, Mandel ID. Salivary gland dysfunction and swallowing disorders. Otolaryngol Clin North Am 1988;21:649-61.
  2. Blasco PA, Allaire JH. Drooling in the developmentally disabled: management practices and recommendations. Consortium on Drooling. Dev Med Child Neurol 1992;34:849-62.
  3. Jongerius PH, Rotteveel JJ, van den Hoogen F, Joosten F, van Hulst K, Gabreëls FJ. Botulinum toxin A: a new optionfor treatment of drooling in children with cerebral palsy. Presentation of a case series. Eur J Pediatr 2001;160:509-12.
  4. Crysdale WS, White A. Submandibular duct relocation for drooling: a 10-year experience with 194 patients. Otolaryngol Head Neck Surg 1989;101:87-92.
  5. Porta M, Gamba M, Bertacchi G, Vaj P. Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders. J Neurol Neurosurg Psychiatry 2001;70:538-40.
  6. Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 2002;112:73-81.
  7. Hockstein NG, Samadi DS, Gendron K, Handler SD. Sialorrhea: a management challenge. Am Fam Physician 2004;69:2628-34. Sochaniwskyj AE. Drool quantification: noninvasive technique. Arch Phys Med Rehabil 1982;63:605-7.
  8. Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988;3:73-8.
  9. Camp-Bruno JA, Winsberg BG, Green-Parsons AR, Abrams JP. Efficacy of benztropine therapy for drooling. Dev Med Child Neurol 1989;31:309-19.
  10. Alataş N, Yazgan P, Oztürk A, San I. The efficacy of botulinum toxin-A in the treatment of hypersalivation in children with cerebral palsy. [Article in Turkish] Kulak Burun Bogaz Ihtis Derg 2006;16:49-53.
  11. Harris SR, Purdy AH. Drooling and its management in cerebral palsy. Dev Med Child Neurol 1987;29:807-11. Crysdale WS. Drooling. Experience with team assessment and management. Clin Pediatr (Phila) 1992;31:77-80. Daniel SJ. Multidisciplinary management of sialorrhea in children. Laryngoscope 2012;122(Suppl 4):S67-8. Tenhunen M, Collan J, Kouri M, Kangasmäki A, Heikkonen J, Kairemo K, et al. Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer. Radiother Oncol 2008;87:260-7.
  12. Daniel SJ, Blaser S, Forte V. Unilateral agenesis of the parotid gland: an unusual entity. Int J Pediatr Otorhinolaryngol 2003;67:395-7.
  13. Sochaniwskyj AE, Koheil RM, Bablich K, Milner M, Kenny DJ. Oral motor funct